Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 11, 2024 · Filed Oct 16, 2024
A Zevra Therapeutics director paid $4K out of pocket for Zevra Therapeutics shares. It was the first purchase in over a year. Shares held went up 50% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$3,958
Shares × reported transaction price
<$25K
+50.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
None in 12 months of history
Confirmed open-market purchases by the same insider in the available history
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
59 days after results of Aug 13, 2024, 32 days before results of Nov 12, 2024
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −7.4% | −0.5% | −6.9% |
| 30 days | +0.8% | +1.0% | −0.2% |
| 90 days | −6.1% | +1.8% | −7.9% |
| 180 days | −18.4% | −7.7% | −10.7% |
| 365 days | +26.7% | +14.1% | +12.6% |
Past results only. Not a forecast.